|
|
|
Volumn 62, Issue SUPPL. 22, 2001, Pages 29-32
|
|
Risperidone for the treatment of behavioral and psychological symptoms of dementia
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CLOZAPINE;
HALOPERIDOL;
NEUROLEPTIC AGENT;
OLANZAPINE;
QUETIAPINE;
RISPERIDONE;
AGED;
AGGRESSION;
AGITATION;
BEHAVIOR DISORDER;
CLINICAL TRIAL;
COGNITIVE DEFECT;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEMENTIA;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
EXTRAPYRAMIDAL SYMPTOM;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MENTAL DISEASE;
PRIORITY JOURNAL;
PSYCHOSIS;
SYMPTOMATOLOGY;
TARDIVE DYSKINESIA;
AGED;
AGGRESSION;
ANTIPSYCHOTIC AGENTS;
BASAL GANGLIA DISEASES;
CLINICAL TRIALS;
COGNITION DISORDERS;
DEMENTIA;
DYSKINESIA, DRUG-INDUCED;
HUMANS;
INCIDENCE;
PSYCHIATRIC STATUS RATING SCALES;
PSYCHOMOTOR AGITATION;
PSYCHOTIC DISORDERS;
RISPERIDONE;
TREATMENT OUTCOME;
|
|
EID: 0034791494
PISSN: 01606689
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (9)
|
|
References (15)
|
